Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by hmmmmmmmmon Apr 25, 2024 6:47pm
316 Views
Post# 36008284

RE:The San Diego Spectral/PMX presentation.

RE:The San Diego Spectral/PMX presentation. This is a good find. Dr. Danielle Davison is very good- really well spoken, a great presentation- much sharper than any others we've heard from Spectral. She should present regularly.

A couple interesting moments that stood out.

39:00 it's very interesting to hear the ICU nurses discuss the 
blinded Euphrates trial- and how positive and obvious the changes were to patients who recieved PMX vs placebo.

55:00 These Colorado ICU/ charge nurses make it clear how much effort is needed at the trial sites to keep PMX at the front of mind with Dr.s, and to identify/ enroll possible trial patients. It's been clear for years that enrollment numbers are directly tied to daily, relentless, leadership on the ground- these nurses make that point crystal clear.
<< Previous
Bullboard Posts
Next >>